Technology Details:
• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) commonly called as coronavirus-the etiological agent of COVID-19 in humans, has been shown to readily infect and occasionally cause death in cat, dog, deer, lions/tigers/leopards and minks. :
• In India, SARS-CoV-2 Delta (identical to human SARS-CoV-2 Delta strains) infection has been reported in lions; other pet animals (dogs, cats) are also at high risk due to their close contact with human population. Jumping of SARS-CoV-2 from humans to animals might accelerate its evolution and hence affect surveillance and control strategies of COVID-19 in humans. :
• SARS-CoV-2 vaccination in animals is not only essential to prevent SARS-CoV-2 transmission from animal-to-animal but also its transmission back to humans. Besides,vaccination in animals is also likely to limit the emergence of SARS-CoV-2 variants.:
• A single dose of vaccine contains 10 µg of ?-Propiolactone inactivated and Alhydrogel adjuvanted SARS-CoV-2 (Delta) antigen. SARS-CoV-2(Delta) was isolated from a COVID-19 confirmed patient. The Ancovax is safe and induces a potent neutralizing antibody- and cell-mediated immune response against SARS-CoV-2 in laboratory animals (mice/rabbits) and dogs, thereby it prevents SARS-CoV-2 infection in animals.:
• Dose and route of administration is 1 ml via subcutaneous (s/c) route.:
• The vaccine must be stored at 4oC and is stable up to 1 year.: